Phagenesis: Improving outcomes for patients with stroke and brain trauma
Dysphagia is the medical term for difficulty in swallowing and is a relatively common complaint amongst inpatients who are admitted to NHS hospitals or chronic care facilities.
Patients with dysphagia are at a high risk of pulmonary aspiration and subsequent pneumonia secondary to food or liquids entering the lungs instead of the stomach. Potentially severe complications for the individual and costs to the healthcare system can result.
Phagenesis, a start-up company developing a device to treat dysphagia, is located within the MedTECH Centre, a facility established in partnership with Central Manchester University Hospitals NHS Foundation Trust (CMFT) and Manchester Science Parks.
The device is based on technology developed by Dr Shaheen Hamdy, a clinical academic at The University of Manchester and a consultant at Salford Royal NHS Foundation Trust.
Phagenesis Ltd was the first company to take space in the MedTECH centre and was also supported by MIMIT in its development stages. After a series of funding rounds, the latest of which raised €7.5m, the company now employs ten staff and launched their product Phagenyx, in 2012. Phagenesis also won the ‘Healthcare Project of the Year’ at the Bionow North of England Awards 2012.
Find out more: www.phagenesis.com